Company Interview / Partner content

Andreas Fouras, CEO of 4DMedical explains its lung imaging technology, and how it is advancing respiratory health. With US FDA approval, the company's products aim to capture a significant portion of the $30 billion lung health market. Andreas sees the 4DMedical tech as a response to the limitations of existing diagnostic options.

4DMedical continues to expand its market presence through strategic partnerships. Andreas says partnering with UC San Diego Health aligns the company with academic leaders in the lung space, paving the way for future expansion. Andreas views this as a critical step in making their lung imaging products more adopted.

Andreas sees an opportunity for 4DMedical to showcase its tech at the Radiological Society of North America conference. Co-presenting with Philips Healthcare, it aims to attract the attention of 65,000 doctors. Andrea's expects the exercise to enhance 4DMedical's visibility and business opportunities significantly.

*The information contained in this event is general in nature and is not intended as advice. 

Before acting on information you've seen or heard at this event, you should seek professional financial advice which takes into account your personal circumstances. 

You should be aware that companies presenting do so under commercial agreement with AUSBIZ CAPITAL PTY LTD